Morgan Stanley’s PhaseRx, Inc. PZRX Stock Holding History

Morgan Stanley’s Portfolio PZRX Stock Details PZRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-199	Closed	–	–	6793
2017 Q3	$0	Buy	199 +126	+173%	+$94	﹤0.01%	6710
2017 Q2	$0	Buy	+73	New	+$86	﹤0.01%	6740
2016 Q3	–	Sell	-100	Closed	–	–	6625
2016 Q2	$0	Buy	+100	New	+$494	﹤0.01%	6799

Other funds holding PZRX

RFC

Regions Financial Corp Birmingham, Alabama $15.4B AUM 21.7% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Morgan Stanley's PZRX Position: Q4 2017 in Review

Morgan Stanley sold out of PhaseRx, Inc. (PZRX) in Q4 2017, closing a stake of 199 shares.

Morgan Stanley first reported a position in PZRX in Q2 2016 and held it in 3 quarters. The position peaked at $0 in Q3 2017. 6 funds tracked by Wall St. Rank hold PZRX as of Q4 2017.

Morgan Stanley reported no remaining PhaseRx, Inc. position as of Q4 2017 after selling out during the quarter.
Morgan Stanley sold 199 PhaseRx, Inc. shares in Q4 2017.
Morgan Stanley first reported a position in PhaseRx, Inc. in Q2 2016 and held it in 3 quarters.
Morgan Stanley's PhaseRx, Inc. position peaked at $0 in Q3 2017.
6 funds tracked by Wall St. Rank held PhaseRx, Inc. as of Q4 2017.

Based on Morgan Stanley's 13F filing for Q4 2017, filed 14 Feb 2018.